Literature DB >> 26125305

Psychosocial consequences of living with breathlessness due to advanced disease.

Daisy J A Janssen1, Emiel F M Wouters, Martijn A Spruit.   

Abstract

PURPOSE OF REVIEW: Breathlessness is one of the most important symptoms of patients with advanced life-limiting disease, such as chronic obstructive pulmonary disease, chronic heart failure, cancer, or pulmonary fibrosis. Breathlessness has major implications for patients as well as their family caregivers. The present review provides an overview of recent knowledge concerning the psychological and social consequences of breathlessness, including behavioural responses to breathlessness, and the impact of breathlessness on the family caregiver. RECENT
FINDINGS: Breathlessness results in avoidance of exertion and deterioration of functional status. Functional impairment leads to care dependency and social limitations, resulting in a change in social role. Anxiety is an emotional response to breathlessness, but also increases the perception of breathlessness. Family caregivers of patients have to cope with changes in daily life, witnessing breathlessness and adapt to new and challenging role as family caregiver.
SUMMARY: The consequences of living with breathlessness are multidimensional and arise in all aspects of daily life of patients, their family caregivers and their social environment. Multidimensional treatment programmes should become widely available to support patients with advanced disease and their family caregivers in coping with the functional, psychological and social consequences of living with breathlessness.

Entities:  

Mesh:

Year:  2015        PMID: 26125305     DOI: 10.1097/SPC.0000000000000146

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  8 in total

Review 1.  Optimizing quality of life in patients with idiopathic pulmonary fibrosis.

Authors:  Mirjam J G van Manen; J J Miranda Geelhoed; Nelleke C Tak; Marlies S Wijsenbeek
Journal:  Ther Adv Respir Dis       Date:  2017-01-01       Impact factor: 4.031

2.  Persisting breathlessness and activities reduced or ceased: a population study in older men.

Authors:  Slavica Kochovska; David Currow; Sungwon Chang; Miriam Johnson; Diana Ferreira; Deidre Morgan; Max Olsson; Magnus Ekström
Journal:  BMJ Open Respir Res       Date:  2022-05

3.  Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO.

Authors:  Marlies van Dijk; Jorine E Hartman; Karin Klooster; Nick H T Ten Hacken; Huib A M Kerstjens; Dirk-Jan Slebos
Journal:  Respiration       Date:  2020-01-21       Impact factor: 3.580

4.  What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany.

Authors:  Mirjam J G van Manen; Michael Kreuter; Bernt van den Blink; Ute Oltmanns; Karin Palmowski; Eva Brunnemer; Simone Hummler; Nelleke C Tak; Leon van den Toorn; Jelle Miedema; Henk C Hoogsteden; Marlies S Wijsenbeek
Journal:  ERJ Open Res       Date:  2017-02-14

5.  The physical, mental, and social impact of COPD in a population-based sample: results from the Longitudinal Aging Study Amsterdam.

Authors:  Frits M E Franssen; Dionne E Smid; Dorly J H Deeg; Martijn Huisman; Jan Poppelaars; Emiel F M Wouters; Martijn A Spruit
Journal:  NPJ Prim Care Respir Med       Date:  2018-08-10       Impact factor: 2.871

6.  Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness.

Authors:  Daisy J A Janssen; Marieke H J van den Beuken-van Everdingen; Cornelia A Verberkt; Jacques P H M Creemers; Emiel F M Wouters
Journal:  Breathe (Sheff)       Date:  2019-09

7.  Shortness of Breath on Day 1 After Surgery Alerting the Presence of Early Respiratory Complications After Surgery in Lung Cancer Patients.

Authors:  Qingsong Yu; Hongfan Yu; Wei Xu; Yang Pu; Yuxian Nie; Wei Dai; Xing Wei; Xin Shelley Wang; Charles S Cleeland; Qiang Li; Qiuling Shi
Journal:  Patient Prefer Adherence       Date:  2022-03-19       Impact factor: 2.711

Review 8.  Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).

Authors:  Marlies van Dijk; Kris J M Mooren; Jan-Willem K van den Berg; Wendy J C van Beurden-Moeskops; Roxane Heller-Baan; Sander M de Hosson; Wai Yee Lam-Wong; Liesbeth Peters; Karin Pool; Huib A M Kerstjens
Journal:  BMC Pulm Med       Date:  2021-09-10       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.